[
  {
    "ts": null,
    "headline": "Boston Scientific (BSX) Sees a More Significant Dip Than Broader Market: Some Facts to Know",
    "summary": "Boston Scientific (BSX) closed at $90.53 in the latest trading session, marking a -0.34% move from the prior day.",
    "url": "https://finnhub.io/api/news?id=d12260c46108a1db2c79249b1d46b33a17f64043da002be863ad7a938a33bb88",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733439606,
      "headline": "Boston Scientific (BSX) Sees a More Significant Dip Than Broader Market: Some Facts to Know",
      "id": 131813173,
      "image": "https://media.zenfs.com/en/zacks.com/c2fdcaac033e049c74f38d188afcc9f9",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) closed at $90.53 in the latest trading session, marking a -0.34% move from the prior day.",
      "url": "https://finnhub.io/api/news?id=d12260c46108a1db2c79249b1d46b33a17f64043da002be863ad7a938a33bb88"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors",
    "summary": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=88c864f6366bbe307c19c6cd4a227fa229de4211356ea8a72e4ae05628e31c75",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733416860,
      "headline": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors",
      "id": 131876932,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=88c864f6366bbe307c19c6cd4a227fa229de4211356ea8a72e4ae05628e31c75"
    }
  },
  {
    "ts": null,
    "headline": "Should You Continue to Retain QIAGEN Stock in Your Portfolio Now?",
    "summary": "QGEN's robust expansion of its testing menu and potential in molecular diagnostics bode well for investors.",
    "url": "https://finnhub.io/api/news?id=ca6086700119f52f2789ac973bea0f046ff23b74d9a9b3b347d39f650a7b6db6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733402760,
      "headline": "Should You Continue to Retain QIAGEN Stock in Your Portfolio Now?",
      "id": 131794823,
      "image": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "QGEN's robust expansion of its testing menu and potential in molecular diagnostics bode well for investors.",
      "url": "https://finnhub.io/api/news?id=ca6086700119f52f2789ac973bea0f046ff23b74d9a9b3b347d39f650a7b6db6"
    }
  }
]